Five years of T1DX QI Collaborative and Reimagining the Future of Diabetes Care 11/8/2021 - 11/9/2021

By the end of this learning session, we want participants to:

Know: The work and accomplishments in the the last five years of the QI Collaborative work in improvement science and understand where population health is headed

Feel: Energized that teams have the tools to effectively mobilize and optimistic about the resources shared across the QI Collaborative.

Do:

  1. PDSA cycles to improve and address key drivers in clinical practice
  2. PDSA cycles to address interventions that support key drivers for the collaborative aim
  3. PDSA cycles to maintain/sustain the gains made in the interventions tested over the last 5 years

Target Audience

This activity has been designed to meet the educational needs of Endocrinologists, PCPs, pharmacists, physician assistants, nurses, nurse practitioners, QI Specialists who are involved in the care and treatment of patients with Type 1 diabetes. 

 

 

Learning Objectives

At the conclusion of this activity, participants will be able to:

  1. Describe the future of novel therapies, interventions, quality improvements, and solutions to today’s diabetes care challenges.
  2. Identify gaps in population health needs and state 3 ways they can be improved over the next 5 years
  3. Apply the strategies of the T1DX-QI Equity Framework which can help to improve diabetes health outcomes for BIPOC T1D and T2D patients
  4. Discuss expectations for patient care and patient engagement and describe ways to co-design care with patients

 

Course summary
Available credit: 
  • 8.75 AMA PRA Category 1 Credit™
    Boston University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Boston University School of Medicine designates this Enduring activity for a maximum of 8.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 8.75 ANCC
    Boston University School of Medicine Continuing Nursing Education is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
    • 3.00 ANCC Pharmacology
  • 8.75 Participation
Course opens: 
11/08/2021
Course expires: 
11/09/2022

Day One: November 8th (all times reflect Eastern Standard) 

11:00 – 11:30 
Welcome Agenda Overview, Logistics, Know, Feel, Do
Boston Medical Center introduction and Welcome

Nicole Rioles, MA
Devin Steenkamp, MBChB & BMC Team

11:30 – 12:15
Celebrating our past and envisioning our future: Showcasing the strength, achievements, and power of Learning Networks.

Stephen Muething MD, Chief Quality Officer, Cincinnati Children Hospital

12:15 – 12:45
QI Collaborative Journey

Osagie Ebekozien, MD, MPH

12:45 – 1:00
T1D Exchange

Dave Walton

1:00 – 1:15
Break

1:15 – 2:05
Breakout Session #1

  1. Key Driver Diagram Highlights [10 sites]
      Ori Odugbesan, MD, MPH
      Ann Mungmode, MPH

  2.Innovation in pediatrics care
      Dan DeSalvo, MD
      Linda A. DiMeglio, MD
  
  3. Five years of innovation in adult management in the QI Collaborative: How adult care has changed in the last five Years
      Ilona Lorincz, MD
      Carol Levy, MD, CDE

  4a. Boston Medical Center’s ACO-funded CGM enhanced eConsult Program
  4b. Cultural Humility with Latino Families
       Kathryn Fantasia, MD
       Ariana Hoet, Ph.D.
       Lorena Asadi, MSW, LISW
 
2:05 – 2:35
Nourishing our Community: Use of Teaching Kitchen, Rooftop Farm, and Preventive Food Pantry in Diabetes Care

Ivania Rizo, MD
Olivia Weinstein, MS, RD, LDN

2:35 – 2:50
Break – Mindfulness/meditation with stretch with Bryce Farrell

2:50 – 3:35
Break Out Session #2

  1. Diabetes Data Rounds:The Endocrinologist’s EKG
      Aaron Neinstein, MD

  2. Equity-themed abstracts
      Moderator: Kristina Cossen, MD

     Reducing pediatric healthcare disparities in use of technology in Type 1 diabetes patients
       Kajal Gandhi, DO, MPH

     Pediatric Type 1 Diabetes Technology Use: Black Parent’s Perspective
       Mariaester Morillo, MD

     Improvement in Equity of CGM Prescriptions After Targeted Interventions
       Priyanka Mathias, MD  

  3. A1c and Measures-themed abstracts:
      Moderator: Todd Alonso, MD

      Implication of device disengagement on glycemic targets and Diabetic ketoacidosis in youth with T1D
        Diana Ferro, PhD

      Benchmarking HbA1c Targets across T1D Exchange Quality Improvement Pediatric Clinics
        Ann Mungmode, MPH

      Six Habits
       Joyce Lee, MD, MPH

   4. Flow and pediatric documentation-themed abstracts
      Moderator: Alexis Feuer, MD

     Creating a Comprehensive Diabetes Review Flowsheet
      Patricia Gomez, MD

     Transition Readiness Documentation at a Pediatric Diabetes Center
      Jeniece Ilkowitz, RN, MA CDCES

     Implementation of a Transition Readiness Assessment and Transition Discussion Documentation in a Type 1 Diabetes Clinic
       Sonalee Ravi, MD

3:35 – 3:40
Day 1 Wrap Up Reflections

Manu Kamboj, MD

 

Day Two: November 9th (all times reflect Eastern Standard) 

11:00 – 11:10
Welcome, logistics and overview for day two

Nicole Rioles, MA

11:10 – 11:50
Break Out Session #3

   1.QI Toolkit Overview: QI tools Pick Diagram and Decision Matrix & Baseline Quality Improvement Culture Assessment for Centers Participating in the T1D Exchange QI               Collaborative
         Ori Odugbesan, MD, MPH
         Ann Mungmode, MPH

   2.Data Growth in the Network. EMR data collection Broad and local perspective on the data sharing process
        Mark Clements, MD, PhD
        Todd Alonso, MD

   3.Psychosocial Care
       Sarah Corathers, MD
       Cynthia Muñoz, PhD, MPH

   4. COVID-19
      Moderated by Robert Rapaport, MD, PhD

    4a) Risk Stratification
            Carla Demeterco-Berggren, MD, PhD

    4b) Device use and COVID-19
        Nudrat Noor, PhD, MPH

11:50 – 12:30
Health Equity

Osagie Ebekozien, MD, MPH

12:30 – 12:45  Break

12:45 – 1:30

Breakout Groups #4

  1. Population Health themed abstracts:
      Moderated by Nana-Hawa Jones, MD

     5-Year (2016-2020) Trend of Obesity and Patient Profiles of the Adult Population with Type 1 Diabetes: A U.S. Based Multi-Center Study
         T1DX-QI

     5-Year Trends of Overweight and Obesity (2016-2020) and Patient Profiles of the Pediatric Population with Type 1 Diabetes: A U.S. Based Multi-Center Study
         Nudrat Noor, PhD, MPH

      QI Portal
       Ann Mungmode, MPH

  2. Psychosocial-themed abstracts:
        Moderated by Sarah Corathers, MD

     Improving Depression Screening at a Pediatric Diabetes Center
       Jeniece Ilkowitz, RN, MA, CDCES

     A Whole Child Model of Care for Pediatric Medicaid Patients with Type 1 Diabetes to Address Health Disparities and Close Care Gaps
       Carla Demeterco-Berggren, MD, PhD

    Improving Psychosocial Care To Decrease Diabetic Ketoacidosis In A Population with Type 1 Diabetes: A Series of Quality Improvement Interventions
       Selorm Dei-Tutu. MD, MPH

   3. Equity-themed abstracts
     Moderated by Shivani Agarwal, MD, MPH

     T1D Exchange Technology Equity Improvement Project: Baseline Analysis of Insulin Pump Use
      Ori Odugbesan, MD, MPH

     Reducing Insurance-Based Disparities for Access to Continuous Glucose Monitors & Improving Access to Continuous Glucose Monitors for High-Risk Patients
      Jessica Schmitt, MD

     Medicaid Coverage of Continuous Glucose Monitors in Texas: A Quality Improvement Success Story in Advocacy
      Bonnie McCann-Crosby, MD

    4. Technology
     Moderated by David Maahs, MD, PhD

     Remote Patient Monitoring for Youth with Type 1 Diabetes (T1D) Predicted to Experience a Rise in Hemoglobin A1C (A1c)
       David Williams

     Teamwork, Targets, Technology, and Tight Control (4T Program): Personalized Medicine at Population Scale
       Priya Prahalad, MD, PhD

     Schema and Data Validation of T1D Exchange Mapped Data Using Pandera Framework
       Brent Lockee, BS

1:30 – 2:05
Patient perspectives

Nicole Rioles
Jane Dickinson, PhD, CBDCE
Craig Bobik
Amy Ohmer

2:05 – 2:20 Break

2:20 – 3:10
Panel Discussion: Reimagining the Future
    
Dave Walton, Moderator
Dan DeSavlo, MD
Laurel Koester, MPH
Grazia Aleppo, MD
Crystal Tolliver

3:10 – 3:20
T1DX QI 2021 Awards

Osagie Ebekozien, MD, MPH
Nicole Rioles, MA
David Walton

3:20 – 3:45
Learning Session Wrap Up and Reflections
Sarah Corathers, MD

 

FACULTY

Program Faculty

The following faculty members have no relevant financial relationships to disclose: 

Anisa Abdi; Todd Alonso, MD; Lorena Asadi, MSW, LISW; Craig Bobik; Sarah Corathers, MD; Kristina Cossen, MD;  Selorm Dei-Tutu. MD, MP; Carla Demeterco-Berggren, MD, PhD; Emily Dewit; Jane Dickinson, PhD, CBDCE; Linda A. DiMeglio, MD; Kathryn Fantasia, MD; Diana Ferro, PhD; Mary Pat Gallagher, MD; Kajal Gandhi, DO, MPH; Patricia Gomez, MD; Jeniece Ilkowitz, BSN, RN, MA, CDE; Manu Kamboj, MD; Laurel Koester, MPH; Brent Lockee, BS; Ilona Lorincz, MD; Priyanka Mathias, MD; Bonnie McCann-Crosby, MD; Mariaester Morillo, MD; Stephen Muething, MD; Ann Mungmode, MPH; Cynthia Muñoz, PhD, MPH; Nudrat Noor, PhD, MPH; Amy Ohmer;  Ori Odugbesan, MD, MPH; Priya Prahalad, MD, PhD; Robert Rapaport, MD, PhD.; Sonalee Ravi, MD; Nicole Rioles, MA; Ivania Rizo, MD; Jessica Schmitt, MD; David Walton; Olivia Weinstein, MS, RD, LDN; David Williams

Shivani Agarwal, MD, MPH, is a cosultant for Medtronic Inc. and Beta Bionics.

Grazia Aleppo, MD receives grant support and is a consultant for Eli-Lilly, Dexcom and Insulet; and is a speaker for Dexcom. 
Mark Clements, MD, PhD, is a consultant for Glooko and receives research grant support from Abbott Diabetes Care and Dexcom.

Dan DeSalvo, MD receives grant support and is a consultant for Dexcom and Insulet; and is a speaker for Dexcom. 

Linda Dimeglio, MD is a consultant for Merck and Mannkind and her  institution receives grant support from Amgen Medtronic and Janssen. 

Osagie Ebekozien, MD, MPH receives grant support and is a consultant for Medtronic Diabetes; and receives grant support from Eli Lilly Diabetes.

Ariana Hoet, PhD, is a speaker for PTC Therapeutics.

Nana-Hawa Jones, MD is a consultant and speaker for Medtronic.

Joyce Lee, MD, MPH is a consultant and on the medical advisory board of Good Rx. 

Carol Levy, MD, CDCES,  receives grant support from Insulet, Dexcom, Abbott Diabetes and Tandem Diabetes; and is a consultant for Dexcom.

David Maahs, MD, PhD, receives research support from the NIH, JDRF, NSF, and the Helmsley Charitable Trust and his institution has had research support from Medtronic, Dexcom, Insulet, Bigfoot Biomedical, Tandem, and Roche.  Dr Maahs has consulted for Abbott, Aditxt, the Helmsley Charitable Trust, Sanofi, Novo Nordisk, Eli Lilly, Medtronic, Insulet, Dompe, and Biospex.

Aaron Neinstein, MD is a consultant for Intuity Medical, Eli Lilly/Roche, Medtronic and Steady Health.

Devin Steenkamp, MBChB, Director of the Clinical Diabetes Program at Boston Medical Center and Boston University School of Medicine; program Course Director and member of the T1D Exchange planning committee, is a consultant for Eli Lilly and receives research grant support from Novo Nordisk. 

David Walton is on the advisory board for Diatech Diabetes.


Off-Label Discussion
Carol Levy, MD, CDCES does plan on discussing the unlabeled/investigational uses of CGM in pregnancy. Linda A. DiMeglio, MD does plan on discussing the use of Insulin Human for pediatric use and also using glucagon in pumps. 


Program Planning Committee
The following members of the T1D Exchange planning committee have no relevant financial relationships to disclose: 

Elizabeth Brouillard, RN; CNE Nurse Advisor
Jane Dickinson, PhD, CBDCE;  Nurse Planner and Patient Representative
Emma Ospelt, MPH; T1D Exchange’s Project Manager

 

CME Project Manager: Michael Burk

ACCME Accreditation
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Boston University School of Medicine and T1D Exchange. Boston University School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Boston University School of Medicine designates this live activity for a maximum of 8.75 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

NCPD Accreditation
This educational activity has been provided by Boston University School of Medicine Continuing Nursing Education and jointly-provided by by T1D Exchange.

Boston University School of Medicine Continuing Nursing Education is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.

Contact Hours: 8.75, of which 3 are eligible for pharmacology credit

 

Available Credit

  • 8.75 AMA PRA Category 1 Credit™
    Boston University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Boston University School of Medicine designates this Enduring activity for a maximum of 8.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 8.75 ANCC
    Boston University School of Medicine Continuing Nursing Education is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
    • 3.00 ANCC Pharmacology
  • 8.75 Participation
Please login or register to take this course.